XML 40 R28.htm IDEA: XBRL DOCUMENT v3.25.3
Segments (Tables)
9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table is representative of the significant expense categories regularly provided to the CODM when managing the Company’s single reporting segment.
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Program expenses(1)
atebimetinib (IMM-1-104)$5,091,491 $4,591,547 $14,518,757 $12,045,176 
IMM-6-415292,917 1,212,407 2,195,284 3,372,353 
Other programs1,674,358 1,164,557 4,093,993 4,699,070 
Non-program expenses(2)
1,894,410 1,380,336 4,677,209 4,223,505 
Employee-related costs4,892,610 5,195,836 15,216,089 16,126,828 
Stock-based compensation expense1,456,080 1,640,116 4,673,290 4,776,623 
Depreciation and amortization78,841 88,949 248,628 269,691 
Other segment items(3)
(415,832)(676,382)(1,178,362)(2,528,123)
Net loss$14,964,875 $14,597,366 $44,444,888 $42,985,123 

(1) Includes direct research and development expenses.
(2) Includes general and administrative expenses, in addition to facilities and other research and development expenses.
(3) Includes interest income and other (income) expense.